Your Daily Asia Gaming eBrief: Not until the made-in-China mRNA vaccine

Friday 21st of October 2022

MGM China, Sands China to assist with Macau vaccinations

Good morning. While other Asian markets are enjoying some level of recovery, Macau's outlook remains pretty grim. We reached out to Alidad Tash to go over some of the questions on the industry's minds: Genting, Covid-zero, digital currency, and next year's GGR outlook.
The AGB team looks forward to welcoming the industry tonight at The Peak.

What you need to know

Alidad Tash estimates Macau's 20023 GGR to reach about 40 percent of 2019 levels and that we won't be getting out of a covid zero policy well into the second quarter of next year - once a made-in-China mRNA vaccine has been approved and administered to the vast majority of the Mainland's population. In a special edition of AGB's Face-to-Face sessions, 2NT8's managing director goes over some of the questions on the industry's minds: Genting, Covid-zero, digital currency, next year's GGR outlook.

On the radar

Tourism boon from POGO ban speculative.
CNMI Commission chases IPI for $25mil.

AGB Intelligence

MACAU

Not until a made-in-China mRNA vaccine

Alidad Tash estimates Macau's 2023 GGR to reach about 40 percent of 2019 levels and that we won't be getting out of a covid zero policy well into the second quarter of next year - once a made-in-China mRNA vaccine has been approved and administered to the vast majority of the Mainland's population. In a special edition of AGB's Face-to-Face sessions, 2NT8's managing director goes over some of the questions on the industry's minds: Genting, Covid-zero, digital currency, next year's GGR outlook.